PROJECT UPDATE

Jun 04, 2024

PROJECT UPDATEMe (Dylan Paoletti) and my Mentor (Dr. Peter Evans) are pursuing expansion of the project by founding a Start-Up Company 
(Plasmid Therapeutics)
. We hope to get investments from accelerator and incubator programs like Indie-Bio in NYC to secure funding for In vitro testing on cell lines and cell line panels, followed by animal models using immunocompromised mice models with skin grafts to test the treatment.

Thank you to all those who have pledged your donations thus far. 

Best, 
Dylan & Peter

Dylan like this.

0 comments

Join the conversation!Sign In

About This Project

GC-Therapy: Testing A Completely New Kind of Cancer Treatment

Baltimore Under-Ground Science Space (BUGSS)

Cancer remains one of the most challenging health issues worldwide. Current therapies like chemotherapy, radiation, and surgery often come with significant side effects (off-target effects) and limited effectiveness. To address these limitations, my project proposes leveraging synthetic genetic pathways for cancer therapy. This project capitalizes on the processes involved in DNA damage response to create a targeted and low-cytotoxicity approach to combat cancer.